Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
DEL PRIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership443,924 shares
Latest Disclosed Value $ 1,012,147
Invesco Ltd. reports 13.16% increase in ownership of 9EH / Evolent Health, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 443,924 shares of Evolent Health, Inc. (DE:9EH) valued at $839,016 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 392,282 shares of Evolent Health, Inc.. This represents a change in shares of 13.16% during the quarter. The current value of the position is $1,500,463 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 443,924 51,642 13.16 1,012 -35.50 0.0000
2026-02-19 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 392,282 91,370 30.36 1,569 -38.35 0.0002
2025-11-13 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 300,912 79,619 35.98 2,546 2.17 0.0004
2025-08-13 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 221,293 52,800 31.34 2,492 56.18 0.0004
2025-05-12 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 168,493 52,872 45.73 1,596 22.69 0.0003
2025-02-13 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 115,621 -1,177,724 -91.06 1,301 -96.45 0.0002
2024-11-12 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 1,293,345 -162,939 -11.19 36,576 31.36 0.0071
2024-08-13 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 1,456,284 -502,178 -25.64 27,844 -56.64 0.0059
2024-05-14 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 1,958,462 -115,986 -5.59 64,218 -6.28 0.0138
2024-02-13 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 2,074,448 142,271 7.36 68,519 30.23 0.0163
2023-11-13 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 1,932,177 -1,084,848 -35.96 52,613 -42.45 0.0142
2023-08-11 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 3,017,025 -325,561 -9.74 91,416 -15.72 0.0240
2023-05-12 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 3,342,586 438,179 15.09 108,467 33.00 0.0303
2023-02-13 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 2,904,407 260,307 9.84 81,556 -14.16 0.0239
2022-11-14 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 2,644,100 1,350,003 104.32 95,003 139.05 0.0306
2022-08-15 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 1,294,097 644,960 99.36 39,742 89.55 0.0120
2022-05-16 2022-03-31 13F EVOLENT HEALTH CL A 30050B101 649,137 560,438 631.84 20,967 754.40 0.0053
2022-02-14 2021-12-31 13F EVOLENT HEALTH CL A 30050B101 88,699 -255,155 -74.20 2,454 -76.98 0.0006
2021-11-15 2021-09-30 13F EVOLENT HEALTH CL A 30050B101 343,854 162,609 89.72 10,660 178.55 0.0027
2021-08-17 2021-06-30 13F EVOLENT HEALTH CL A 30050B101 181,245 -257,875 -58.73 3,827 -56.85 0.0009
2021-05-17 2021-03-31 13F EVOLENT HEALTH CL A 30050B101 439,120 238,840 119.25 8,870 176.24 0.0024
2021-02-16 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 200,280 28,668 16.71 3,211 50.75 0.0009
2020-11-16 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 171,612 69,870 68.67 2,130 193.79 0.0007
2020-08-14 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 101,742 -11,051 -9.80 725 18.27 0.0003
2020-05-15 2020-03-31 13F EVOLENT HEALTH CL A 30050B101 112,793 53,077 88.88 613 13.52 0.0003
2020-02-14 2019-12-31 13F EVOLENT HEALTH CL A 30050B101 59,716 -3,825 -6.02 540 18.16 0.0002
2019-11-14 2019-09-30 13F EVOLENT HEALTH CL A 30050B101 63,541 -1,708 -2.62 457 -11.95 0.0001
2019-08-14 2019-06-30 13F/A-1 EVOLENT HEALTH CL A 30050B101 65,249 -362,425 -84.74 519 -90.35 0.0001
2019-08-14 2019-06-30 13F EVOLENT HEALTH CL A 30050B101 65,249 -362,425 519
2019-05-15 2019-03-31 13F EVOLENT HEALTH CL A 30050B101 427,674 75,112 21.30 5,380 -23.51 0.0018
2019-02-14 2018-12-31 13F EVOLENT HEALTH CL A 30050B101 352,562 17,615 5.26 7,034 -26.05 0.0027
2018-11-14 2018-09-30 13F EVOLENT HEALTH CL A 30050B101 334,947 -25,461 -7.06 9,512 25.37 0.0030
2018-08-14 2018-06-30 13F EVOLENT HEALTH CL A 30050B101 360,408 -29,421 -7.55 7,587 36.58 0.0025
2018-05-15 2018-03-31 13F EVOLENT HEALTH CL A 30050B101 389,829 38,697 11.02 5,555 28.62 0.0021
2018-02-14 2017-12-31 13F EVOLENT HEALTH CL A 30050B101 351,132 -1,947,044 -84.72 4,319 -89.44 0.0016
2017-11-14 2017-09-30 13F EVOLENT HEALTH CL A 30050B101 2,298,176 -6,307 -0.27 40,907 -29.98 0.0151
2017-08-14 2017-06-30 13F EVOLENT HEALTH CL A 30050B101 2,304,483 38,749 1.71 58,419 15.62 0.0182
2017-05-15 2017-03-31 13F EVOLENT HEALTH CL A 30050B101 2,265,734 2,119,233 1,446.57 50,526 2,229.46 0.0166
2017-02-14 2016-12-31 13F EVOLENT HEALTH CL A 30050B101 146,501 -76,013 -34.16 2,169 -60.41 0.0007
2016-11-14 2016-09-30 13F EVOLENT HEALTH CL A 30050B101 222,514 222,514 5,479 0.0019
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.